BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14652017)

  • 1. Sialyl-Tn antigen expression and O-linked GalNAc-Thr synthesis by Trypanosoma cruzi.
    Freire T; Robello C; Soulé S; Ferreira F; Osinaga E
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1309-16. PubMed ID: 14652017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Freire T; Casaravilla C; Carmona C; Osinaga E
    Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin-type O-glycosylation in Mesocestoides vogae (syn. corti).
    Medeiros A; Chiribao ML; Ubillos L; Festari MF; Saldaña J; Robello C; Domínguez L; Calvete JJ; Osinaga E
    Int J Parasitol; 2008 Mar; 38(3-4):265-76. PubMed ID: 17892882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
    J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
    Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
    Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
    Gerken TA
    Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning, expression, and characterization of UDP N-acetyl-α-d-galactosamine: Polypeptide N-acetylgalactosaminyltransferase 4 from Cryptosporidium parvum.
    DeCicco RePass MA; Bhat N; Heimburg-Molinaro J; Bunnell S; Cummings RD; Ward HD
    Mol Biochem Parasitol; 2018 Apr; 221():56-65. PubMed ID: 29581010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
    Huang J; Byrd JC; Yoon WH; Kim YS
    Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments.
    Dam TK; Gerken TA; Cavada BS; Nascimento KS; Moura TR; Brewer CF
    J Biol Chem; 2007 Sep; 282(38):28256-63. PubMed ID: 17652089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
    Zhang Y; Iwasaki H; Wang H; Kudo T; Kalka TB; Hennet T; Kubota T; Cheng L; Inaba N; Gotoh M; Togayachi A; Guo J; Hisatomi H; Nakajima K; Nishihara S; Nakamura M; Marth JD; Narimatsu H
    J Biol Chem; 2003 Jan; 278(1):573-84. PubMed ID: 12407114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-N-acetylglucosamine-linked O-glycans of sialoglycoproteins (Tc-mucins) from Trypanosoma cruzi Colombiana strain.
    Todeschini AR; de Almeida EG; Agrellos OA; Jones C; Previato JO; Mendonça-Previato L
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():270-4. PubMed ID: 19753484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation.
    Herbomel GG; Rojas RE; Tran DT; Ajinkya M; Beck L; Tabak LA
    PLoS One; 2017; 12(7):e0179241. PubMed ID: 28719662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.
    Gerken TA; Tep C; Rarick J
    Biochemistry; 2004 Aug; 43(30):9888-900. PubMed ID: 15274643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of α-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruzi.
    Mendonça-Previato L; Penha L; Garcez TC; Jones C; Previato JO
    Glycoconj J; 2013 Oct; 30(7):659-66. PubMed ID: 23430107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.
    George SK; Schwientek T; Holm B; Reis CA; Clausen H; Kihlberg J
    J Am Chem Soc; 2001 Nov; 123(45):11117-25. PubMed ID: 11697954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
    Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
    Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts.
    Inoue M; Takahashi S; Yamashina I; Kaibori M; Okumura T; Kamiyama Y; Vichier-Guerre S; Cantacuzène D; Nakada H
    Cancer Res; 2001 Feb; 61(3):950-6. PubMed ID: 11221889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.